Sign in
WithdrawnNo phase

Maximizing Benefit of Lung Cancer Screening Incidental Findings of Cardiovascular, Respiratory and Breast Measures

Key facts

Who runs it
University of Montana
Trial code
Status
Withdrawn
Started
Dec 2024
Expected to end
Mar 2029
Type of study
Interventional
Treatments tested
  • System implementation of patient-centered incidental findings report
Record updated
9 December 2024
Why it stopped
Not funded by AHRQ

Who can take part

Age
55 years to 80 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Eligible for lung cancer screening program
  • Presence of one of three incidental findings on low dose CT: coronary artery calcification, extensive breast density (for females), or emphysema

Who cannot take part

  • No incidental findings from lung cancer screening low dose CT

About the trial

What the trial wants to find out

The investigators will implement a patient-centered outcomes tool for participants in lung cancer screening programs that receive clinically important incidental findings relevant to heart, breast and lung health. The study objective is to evaluate participant response and clinical follow-up following implementation of a patient-centered incidental findings communication tool.

The group in the trial

  • ImplementationTreatment being tested

    New lung cancer screening participants with clinically significant incidental findings received new patient-centered report

    Treatment: System implementation of patient-centered incidental findings report

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
9 December 2024